690.5000 -11.30 (-1.61%)
NSE Sep 09, 2026 15:31 PM
Volume: 271.1K
 

690.50
-1.61%
Axis Direct
Considering overall stellar performance we have incresed earnings for FY22E & FY23E and increased target price to INR 1,670 with Buy recommendations.
Promoters pledged 5.54% of shares in last quarter. Total pledge stands at 37.11% of promoter holdings
More from Solara Active Pharma Sciences Ltd.
Recommended